Tofacitinib 5 mg: Clinical Trials

4 trials of Tofacitinib 5 mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown, 1 withdrawn. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 2, Unknown 1, Withdrawn 1

Follow Tofacitinib 5 mg: new trials by email Literature Review of Tofacitinib 5 mg trials Research Report on Tofacitinib 5 mg

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
Baricitinib 2mg, Tofacitinib 5 mg - Spondyloarthritis, Axial
Phase 2UnknownBangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh1842023-10-302023-12-21
Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment
GS-5718, Placebo to match GS-5718, Tofacitinib 5 mg - Rheumatoid Arthritis
Phase 2WithdrawnGilead Sciences2022-07-012022-05-18
Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica
Tofacitinib 5 MG - Polymyalgia Rheumatica, Effect of Drug
Phase 2CompletedRenJi Hospital142021-01-012022-09-15
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
Tofacitinib 2 mg, Tofacitinib 5 mg, Tofacitinib 10 mg - Ankylosing Spondylitis
Phase 2CompletedPfizer2082013-04-012016-06-10

Conditions studied

Spondylarthritis (2)  ·  Arthritis, Rheumatoid (1)  ·  Axial Spondyloarthritis (1)  ·  Polymyalgia Rheumatica (1)  ·  Spondylarthropathies (1)  ·  Spondylitis (1)  ·  Spondylitis, Ankylosing (1)

Sponsors

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh (1)  ·  Gilead Sciences (1)  ·  Pfizer (1)  ·  RenJi Hospital (1)

Countries

Bangladesh (1)  ·  Canada (1)  ·  China (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)  ·  United States (1)

Top investigators

Samaresh Das, M B B S (1)  ·  Ting Li, MD (1)

Results publications

PMID 28130206, PMID 36138330, PMID 36604153, PMID 37331992, PMID 37909386, PMID 38696034, PMID 38825359, PMID 39636343, PMID 39695887